Microarray Analysis Market Size, Share, and Growth Analysis, By Product (Consumables, Instruments), By Type (DNA Microarray, Protein Microarray), By Application, By End User, By Region - Industry Forecast 2025-2032
마이크로어레이 분석 시장 규모는 2023년 37억 달러로 평가되었습니다. 2024년 39억 9,000만 달러에서 2032년에는 73억 3,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 7.9%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 마이크로어레이 분석 시장은 기술 발전과 개인 맞춤형 의료에 대한 수요 증가에 힘입어 크게 성장하고 있습니다. 이 높은 처리량 기술은 유전체 연구의 발전과 만성 질환 증가 등의 요인으로 인해 수천 개의 유전자를 동시에 검사할 수 있게 해줍니다. 주요 응용 분야로는 유전자 발현 프로파일링, 유전자형 분석, 바이오마커 탐색 등이 있으며, 대규모 유전자 연구와 신약개발을 가능하게 함으로써 유전체학 및 분자생물학 연구에 혁신을 가져왔습니다. 마이크로어레이 분석과 차세대 시퀀싱, 바이오인포매틱스 등 신기술과의 시너지 효과가 시장 확대를 더욱 촉진하고 있습니다. 북미는 탄탄한 연구 인프라로 인해 여전히 지배적인 시장이지만, 아시아태평양은 신흥 경제국들이 마이크로어레이 기술을 채택하고 개인 맞춤형 의료 및 진단 분야의 지속적인 기술 혁신을 위해 시장을 포지셔닝하고 있어 빠른 성장이 예상됩니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 규제 상황
- 사례 연구
마이크로어레이 분석 시장 규모 : 제품별&CAGR(2025-2032년)
마이크로어레이 분석 시장 규모 : 유형별&CAGR(2025-2032년)
- 시장 개요
- DNA 마이크로어레이
- 단백질 마이크로어레이
- 기타
마이크로어레이 분석 시장 규모 : 용도별&CAGR(2025-2032년)
- 시장 개요
- 연구
- Drug Discovery
- 질병 진단
- 기타 용도
마이크로어레이 분석 시장 규모 : 최종사용자별&CAGR(2025-2032년)
- 시장 개요
- 연구 및 학술기관
- 제약 기업 및 바이오테크놀러지 기업
- 진단 실험실
- 기타
마이크로어레이 분석 시장 규모 : 지역별&CAGR(2025-2032년)
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 전년대비 매출 비교(2022-2024년)
주요 기업 개요
- Illumina, Inc.(United States)
- Agilent Technologies, Inc.(United States)
- Thermo Fisher Scientific, Inc.(United States)
- Merck KGaA(Germany)
- PerkinElmer, Inc.(United States)
- Arrayit Corporation(United States)
- Bio-Rad Laboratories, Inc.(United States)
- GE Healthcare(United States)
- Molecular Devices, LLC.(United States)
- Affymetrix(United States)
- Applied Microarrays, Inc.(United States)
- Oxford Gene Technology(United Kingdom)
- CapitalBio Corporation(China)
- Macrogen, Inc.(South Korea)
- LC Sciences(United States)
- Scienion AG(Germany)
- Arrayjet Ltd.(United Kingdom)
- RayBiotech, Inc.(United States)
- Genotypic Technology Pvt. Ltd.(India)
- Microarrays Inc.(United States)
결론과 제안
LSH
Microarray Analysis Market size was valued at USD 3.7 billion in 2023 and is poised to grow from USD 3.99 billion in 2024 to USD 7.33 billion by 2032, growing at a CAGR of 7.9% during the forecast period (2025-2032).
The global Microarray Analysis Market is experiencing significant growth, fueled by technological advancements and the rising need for personalized medicine. This high-throughput technique allows for the simultaneous examination of thousands of genes, driven by factors like genomic research advancements and the increasing incidence of chronic diseases. Key applications include gene expression profiling, genotyping, and biomarker discovery, which have transformed genomics and molecular biology research by enabling large-scale gene studies and drug discovery. The synergy between microarray analysis and emerging technologies such as next-generation sequencing and bioinformatics further propels market expansion. While North America remains the dominant player due to robust research infrastructure, the Asia-Pacific region is set for rapid growth as emerging economies embrace microarray technologies, positioning the market for ongoing innovation in personalized medicine and diagnostics.
Top-down and bottom-up approaches were used to estimate and validate the size of the Microarray Analysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Microarray Analysis Market Segments Analysis
Global Microarray Analysis Market is segmented by Product, Type, Application, End User and region. Based on Product, the market is segmented into Consumables, Instruments, Software and Services. Based on Type, the market is segmented into DNA Microarray, Protein Microarray and Others. Based on Application, the market is segmented into Rese arch Applications, Drug Discovery, Disease Diagnostics and Others Applications. Based on End User, the market is segmented into Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Microarray Analysis Market
A significant catalyst for the Global Microarray Analysis Market is the rising demand for personalized medicine. This innovative medical approach focuses on customizing treatments for individual patients by taking into account their unique genetic profiles, leading to more accurate and effective therapeutic strategies. In this context, microarray analysis is essential, as it delivers extensive genomic data and assists in pinpointing genetic variations linked to diseases. As personalized medicine continues to gain traction globally, the need for microarray analysis technology intensifies, further propelling market expansion and innovation in the field of genomics and healthcare.
Restraints in the Microarray Analysis Market
A significant limitation facing the Global Microarray Analysis Market is the substantial financial burden linked to microarray technologies and their analysis. The expense associated with microarray platforms, reagents, and instruments can render them inaccessible to numerous research institutions and healthcare facilities that operate under tight budget constraints. Furthermore, the intricate nature of data analysis, combined with the necessity for specialized knowledge, exacerbates the cost issue. This financial challenge is particularly pronounced in resource-limited contexts, stifling broader adoption and growth within the market. Addressing this restraint requires efforts aimed at cost reduction and enhancing affordability through technological innovations and optimized workflows.
Market Trends of the Microarray Analysis Market
The Global Microarray Analysis Market is currently witnessing a notable trend characterized by the integration of microarray technologies with other omics platforms, particularly next-generation sequencing (NGS) and advanced bioinformatics tools. This convergence enhances data analysis capabilities, enabling researchers to achieve a holistic view of biological systems through a detailed examination of the genome, transcriptome, and epigenome. By combining these powerful technologies, scientists can gain deeper insights into gene expression, genetic variations, and complex biological processes related to diseases and personalized medicine. This trend not only promotes innovative research methodologies but also drives the demand for integrated solutions that facilitate multi-dimensional molecular profiling, positioning microarray analysis as a vital component in the evolving landscape of genomics and biotechnology.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Regulatory Landscape
- Case Studies
Global Microarray Analysis Market Size by Product & Services & CAGR (2025-2032)
- Market Overview
- Consumables
- Instruments
- Software
- Services
Global Microarray Analysis Market Size by Type & CAGR (2025-2032)
- Market Overview
- DNA Microarray
- Protein Microarray
- Others
Global Microarray Analysis Market Size by Application & CAGR (2025-2032)
- Market Overview
- Research Applications
- Drug Discovery
- Disease Diagnostics
- Others Applications
Global Microarray Analysis Market Size by End User & CAGR (2025-2032)
- Market Overview
- Research and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Others
Global Microarray Analysis Market Size & CAGR (2025-2032)
- North America (Product & Services, Type, Application, End User)
- Europe (Product & Services, Type, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product & Services, Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product & Services, Type, Application, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product & Services, Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arrayit Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Molecular Devices, LLC. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Affymetrix (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Applied Microarrays, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Gene Technology (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CapitalBio Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Macrogen, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LC Sciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Scienion AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arrayjet Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RayBiotech, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genotypic Technology Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Microarrays Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
